AMGN - CIK 0000318154
The table below shows AMGEN INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B | $10.50B |
| Capital expenditure | $1.86B | $1.10B | $1.11B | $936.00M | $880.00M | $608.00M |
| Investing cash flow | -$1.94B | -$1.05B | -$26.20B | -$6.04B | $733.00M | -$5.40B |
| Dividends paid | $5.12B | $4.83B | $4.56B | $4.20B | $4.01B | $3.75B |
AMGEN INC reported operating cash flow of $9.96B for fiscal year 2025. That is down 13.3% from $11.49B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $10.35B (FY 2016) to $9.96B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $0.00 | $200.00M | $0.00 | $6.36B | $4.97B | $3.49B |
| Financing cash flow | -$10.86B | -$9.41B | $21.05B | -$4.04B | -$8.27B | -$4.87B |